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The case of synchronous fallopian tube and endometrium cancer.  
Clinical observation
A. M. Romaniuk, N. I. Gyryavenko, M. S. Lуndіn, V. V. Sikora, A. M. Piddubnyi
Sumy State University, Ukraine
Background. The problems of pre-operative cancer diagnosis of the fallopian tube are associated with a rare occurrence 
of this disease. More rarely, there is a combination of the fallopian tube cancer and other gynecological tumors. Clinical ob-
servation of the fallopian tube cancer and endometrial cancer in postmenopausal woman is presented, which demonstrates 
the difficulty of the pre-operative diagnostics of these pathologies combination.
Case presentation. We described a case of uterine tube cancer in Ukrainian woman (77 years), which had been combined 
with adenocarcinoma of an endometrium.
Conclusion. Primary fallopian tubes carcinoma is a rare disease with an insufficiently studied etiology. The clinical manifestations 
are not always present in full. Diagnosis in pre-operative period is very hard to establish. Only the qualitative morphological 
investigation allows establishing the primary lesion of the fallopian tube. Introducing immunohistochemical investigations in 
practice serves as additional methods for correct diseases diagnostic, which allow more fully characterizing the prognosis 
and suggesting appropriate treatment of the patients.
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Випадок синхронного раку маткової труби та ендометрія. Клінічне спостереження










досліджень у практику є додатковим методом для правильної діагностики  захворювань,  які дають  змогу  точніше 
охарактеризувати прогноз і запропонувати адекватні методи лікування пацієнтів.
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To date, the fallopian tube tumors are ranged from 0.3 % 
to 1.1 % of all malignant tumors of the female genital 
organs, being the most rare oncogynecology disease 
[1]. It was described for the first time in 1847 by Reno. 
According to available statistics, in average 3.6 cases of 
malignant fallopian tube tumors per 1 million women [2,3] 
are registered annually in the United States. The most 
of the malignant fallopian tube tumors have epithelial 
nature and are presented by serous adenocarcinomas 
(60–90 %); however, in practical activities almost all 
morphological forms of epithelial and stromal neoplasms 
occur  [4]. Diagnostics  of  this  tumor  is  difficult,  due  to 
the low severity of the clinical picture. According to lite-
rature data, the frequency of the diagnosis of this patho-
logy on pre-operative stage fluctuates up to 21 % [3,5]. 
Case report
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Sometimes the fallopian tube cancer (FTC) is a random 
finding during the surgery on the uterus and parovarium 
with other diseases. More than 60 % cases of the FTC 
occur with postmenopausal women [6]. However till now 
the risk factors of this disease remain insufficiently stu-
died. These include reproductive tract infections, genetic 
factors (the presence of the defective gene BRCA1 and 




in oncogynecology ranges to 6 % cases maximum [8], 
even more rarely it is possible to find a combination of 
the fallopian tube tumors and other gynecological tumors. 
We present a clinical case of the patient with the primary 
fallopian tube cancer (PFTC) in combination with en-




A 77-year-old Ukrainian female patient was admitted to 
the Clinical Oncological Dispensary with complaints on 
bleeding from the genital organs. Menopause is during 
24 years. Complaints have appeared about a year ago. 
A family oncological anamnesis of the patient was not 
burdened. Gynecological examination revealed that 
the uterus is not enlarged, relatively movable, uterine 
appendages are not palpable.
The transvaginal ultrasound examination: endome-
trial hyperplasia with increased vascularization, uterine 
appendages are unchanged (Fig. 1).
In order to establish the diagnosis endometrial biopsy 
in the dashed scrapings form was performed. The result of 
histological examination showed growth of the highly dif-
ferentiated endometrioid adenocarcinoma (ICD – C 54.1).
After X-ray examination of lungs pathological changes 
were not found. Laboratory researches showed the pre-
sence of the leukocytosis (12.5 × 109) in the blood, but 
the other indicators were presented in the normal range.
The diagnosis was the following: a malignant neo-
plasm of the uterus body (endometrium), st.1, gr.2; and 
she has been operated – hysterectomy with uterine 
appendages, resection of the greater omentum.
Intraoperative: the uterus was not enlarged, the tumor 
was located in the uterus cavity, in the form of friable 
sebaceous growths. The right and left ovaries, right 
fallopian tube were not changed. The left fallopian tube 




On the left, fallopian tube in the sacculated tumor 
mass form, on the cut in the form of a cauliflower; the left 
ovary is normal (1). In the uterine cavity the tumor is in 
the form of loose sebaceous growths (2).
Histological tissue characteristics were studied with 
using of serial stepped sections, stained with hematoxylin 
and eosin. The result of histological studies: 1. Endo-
metrium tumor – highly differentiated endometrial ade-
nocarcinoma with superficial  invasion into myometrium 
(M8140/3 G1 – the absence areas of a solid structure, with 
prevalence of low nuclei atypia of the epithelial cells) (Fig. 
3-1). 2. The left fallopian tube tumor – serous papillary 
adenocarcinoma of the fallopian tube with tumor invasion 
into  the muscle  layer  (M8441/3 G2 – tumor consisting 
of short papillary structures with dense fibrous stroma, 
atypia, polymorphism and hyperchromatosis of the nuclei, 
and high nuclear cytoplasmic ratio) (Fig. 3-2).
To determine the histogenesis of these neoplasias, 
the stage of their proliferative activity and tumor cells 
anaplasia, characteristics of prediction and selection of 
appropriate methods of patient treatment, we conducted 
the immunohistochemical investigations using the fololow-
ing markers (Table 1).
For immunohistochemical investigations sections 
were produced with  the  thickness of 3–4 mcm, which 
were subjected to the standard process of dewaxing and 
dehydration in xylol and alcohols in rising concentration. 
Immunohistochemical reaction was held in two stages: I – 
Incubation with primary monoclonal antibodies in dilution 
from 1:100 to 1:400, during the 30 minutes (t = 37 °C); 
Fig.  2.  Macroscop ic 
picture of postoperative 
material.
Fig. 1. The transvaginal 
ultrasound examination.
1: uterus;  
2: foci of vascularization.
Table 1. Antibodies for immunohistochemical reaction
Antibody Host Clone Dilution Cellular  
localization
ERα Rabbit SP1 1:200 Nuclear
PR Rabbit YR85 1:150 Nuclear
p53 Mouse SP5 1:100 Nuclear
Кі-67 Rabbit SP6 1:100 Nuclear
Клінічний випадок
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II – Incubation with secondary antibodies (UltraVision), 
during the 30 minutes (t = 37 °C). As a chromogen diami-
nobenzidine (t = 37 °C, 30 minutes) was used with Mayer’s 
hematoxylin staining of the negatively stained nuclei.
The immunohistochemical investigations of the endo-
metrium tumor showed the intensive reaction to the estro-
gen receptors and progesterone. The Ki-67 proliferation 
marker in the endometrium tumor was weakly positive, 
only about 10 % of the nuclei were positive. The negative 
reaction to the anti-p53 antibodies was observed (Fig. 4).
At the same time immunohistochemical investigations 
of the left fallopian tube tumor showed a negative reaction 
to the estrogen and progesterone receptors. Very inten-
sive reaction was observed to the anti-Ki-67 antibodies, 
where more than a 90 % of tumor nuclei were positive. 
Ki-67 is a reliable indicator of proliferation in almost all 
human tumor formations. Also, the intensive reaction was 
observed with anti-p53 antibodies, where more than 90 % 
of tumor cells nuclei were positive (Fig. 5).
This aspect of the immunohistochemistry showed that 
a profound violation of the genetic program with the emer-
gence of mutant p53 gene occurred in this case and a 
relationship between an increase in the expression of p53 
and the growth of morphological atypia and malignancy 
stage was detected.
The postoperative period was unremarkable. At this 
time the patient is on a dynamic observation.
Discussion
PFTC is the most rare malignant tumor of the female 
genital organs [1,9]. To date, in the United States about 
2,000 cases of the PFTC were reported [10]. FTC is 
the most often found after the fourth decades of the life, 
with an average age of 62 years (17–88 years) [11,12]. 
The total five-year survival  ranges  from 14 % to 57 % 
[4,9]. The rare occurrence of the FTC allows asserting that 
the experience of even a small number of observations 
  
Fig. 3. The tumor of endometrium (1) 




Fig. 4. The tumor of endometrium.
1: intensely positive tumor cells for 
estrogen receptors;  
2: intensely positive tumor cells for 
progesterone receptors;  
3: weak positive reaction to the Ki-67; 
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has an undoubted scientific and practical interest. Many 
authors believe that the actual incidence of the PFTC is 
much higher, because the most cases of serous carci-
noma are erroneously diagnosed as ovarian cancer. You 
cannot  find enough  information  in  the  literature about 
the simultaneous presence of endometrium and fallopian 
tube tumors either. These neoplasias at an early stage 
are asymptomatic, in connection with that the diagnosis is 
rarely set on the pre-operative stage. The most common 
symptoms of PFTC are abdominal pain, vaginal bleeding, 
watery discharge from the genital tract, general condition 
impaired and palpation of tumor formation in the pelvis 
[11]. In this case the symptoms were meager, and maybe 
associated with the presence of endometrial tumor. The 
differential diagnosis of these two locations is quite com-
plicated. Determining the level of tumor marker CA-125 
in the blood serum is very important in FTC diagnostics. 
However, in this case, the research was not conducted. 
For better FTC diagnostics it is reasonable to conduct 
a comprehensive survey which includes the ultrasound 
examination, computed tomography, a diagnostic laparos-
copy with biopsy and tumor marker CA-125 determination.
The results of histological and immunohistochemical 
research showed that in this case there were two abso-
lutely different tumors, which have different sensitivity to 
the treatment and prognosis. Moreover, adventitiously 
detected fallopian tube tumor had more unfavorable in-
dicators (a lower degree of differentiation, the absence of 
steroid receptors, high level of the Ki-67 and p53 receptors 
expression), as compared with uterus body tumor.
All aforesaid demonstrates the necessary of indivi-
dual approach to each case of the FTC and requires a 
separate choice of the treatment tactics, with considering 
independent prognostic disease factors.
Conclusion
Primary fallopian tubes carcinoma is a rare disease 
with an insufficiently studied etiology. The clinical mani-
festations are not always present in full. Diagnosis in 
pre-operative period is very hard to establish. Only 
the qualitative morphological investigation allows estab-
lishing the primary lesion of the fallopian tube. Introducing 
immunohistochemical investigations in practice serves 
as additional methods for correct diseases diagnostic, 
which allow more fully characterizing the prognosis and 
suggesting appropriate treatment of the patients.
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Fig. 5. The left fallopian tube.
1: negative tumor cells for estrogen 
receptors;  
2: negative tumor cells for 
progesterone receptors;  
3: intensely positive reaction to 
the Ki-67;  
4: intensely positive reaction to 
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